Additional file 2 of NeuroD1-USP1-MYCN axis drives tumor progression in neuroblastoma
收藏NIAID Data Ecosystem2026-05-10 收录
数据链接：
官方服务：
资源简介：
Supplementary Material 2
应用场景：
创建时间：
2026-02-11
相关数据集
A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma
MYCN amplification (MNA) is a defining feature of high-risk neuroblastoma (NB) that predicts poor prognosis. However, whether genes within or in close proximity to the MYCN amplicon also contribute to
NIAID Data Ecosystem110
Transcriptomic analysis of neuroblastoma cells in response to stable over-expression of cellular nucleic acid binding protein (CNBP)
Cellular nucleic acid binding protein (CNBP) is a 19 kDa conserved protein containing seven tandem cysteine-cysteine-histidine-cysteine zinc finger repeats. However, the action modes and underlying me
NIAID Data Ecosystem50
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma.
MYCN is a master regulator controlling many processes necessary for tumor cell survival. Here, we unravel a microRNA network that causes tumor suppressive effects in MYCN-amplified neuroblastoma cells
NIAID Data Ecosystem40
Genome wide differential gene expression analysis of MYCN-amplified neuroblastoma cells after lncNB1 knockdown with siRNAs. Genome wide differential gene expression analysis of MYCN-amplified neuroblastoma cells after lncNB1 knockdown with siRNAs
We identified that knocking lncNB1 reduces N-Myc protein stability, therefore, we performed affymetrix micoarray studies to investigate whether it was a direct or indirect effect. lncNB1 stabilizes N-
NIAID Data Ecosystem80
A New Module in Neural Differentiation Control: Two MicroRNAs Upregulated by Retinoic Acid, miR-9 and -103, Target the Differentiation Inhibitor ID2
The transcription factor ID2 is an important repressor of neural differentiation strongly implicated in nervous system cancers. MicroRNAs (miRNAs) are increasingly involved in differentiation control
NIAID Data Ecosystem50
